Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 12116597
Autophagy as a therapeutic target for intracranial aneurysm
granted -
US 12116604
Transposase polypeptides and uses thereof
granted -
US 12115149
Formulations, methods, kits, and dosage forms
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12116375
Compositions and methods for treating cancer
granted -
US 12115156
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 12115216
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
granted -
US 12115225
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
granted -
WO 2024209065
NANOÉMULSION SOUS PRESSION
granted -
WO 2024209064
NANOÉMULSION SANS PROPYLÈNE GLYCOL
granted -
WO 2024211523
SCHÉMAS POSOLOGIQUES DESTINÉS À ÊTRE UTILISÉS DANS LA PRÉVENTION DE LA RECHUTE DE LA LEUCÉMIE MYÉLOÏDE AIGUË APRÈS UNE TRANSPLANTATION DE CELLULES SOUCHES HÉMATOPOÏÉTIQUES ALLOGÉNIQUES AVEC DU VÉNÉTOCLAX EN COMBINAISON AVEC DE L'AZACITIDINE
granted -
US 2024335380
NANOEMULSION WITHOUT PROPYLENE GLYCOL
granted -
US 2024335360
PRESSURIZED NANOEMULSION
granted -
AU 2023257308
USES OF FARNESOID X RECEPTOR AGONISTS
granted -
US 12109260
Zika vaccines and immunogenic compositions, and methods of using the same
granted -
US 12110343
Anti-plasma kallikrein antibodies
granted -
US 12109198
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 12109228
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12110491
Selective reduction of allelic variants
granted -
US 12110344
Antibodies that bind to cis and uses thereof
granted -
US 12110315
Fish-derived peptidoglycan recognition protein mutant and application thereof
granted -
US 12109229
Treatment of neurodegenerative disease with sodium chlorite
granted -
US 12109272
Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.